24 May 2013
Keywords: UK, NICE, Eli Lilly, Alimta, NSCLC, Pemetrexed, Lung cancer
Article | 17 December 2009
Giving an initial negative opinion, the UK’s National Institute for Health and Clinical Excellence (NICE) is currently appraising the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.